Reizine Edouard, Mule Sebastien, De Prost Nicolas, Mongardon Nicolas, Deux Jean-François, Kobeiter Hicham, Luciani Alain
Department of Radiology, APHP, Imagerie Medicale, CHU Henri Mondor, 51 avenue du Marechal de Lattre de Tassigny, Creteil, Val-de-Marne F-94010, France.
Faculté de Médecine, Universite Paris Est Creteil, Creteil, F-94010, France.
Res Diagn Interv Imaging. 2022 Mar;1:100001. doi: 10.1016/j.redii.2022.01.001. Epub 2022 Feb 7.
To evaluate and compare the prevalence and type of abdominal involvements identified on CT scans in COVID-19 critically ill patients to those observed in critically ill patients with non-SARS-CoV-2 viral pneumonia.
Monocentric IRB approved retrospective study comparing all abdominal CT scans performed for patients admitted in the ICU with COVID-19 and those performed in a historical cohort of ICU patients with non-SARS-CoV-2 viral pneumonia. For each patient, gallbladder abnormality, acute pancreatitis signs, acute adrenal infarction, renal infarcts, bowel wall thickening and CT scan signs of bowel ischemia were assessed. Results were then compared between critically ill COVID-19 and non-COVID-19 patients (Chi-2 or Fisher exact tests for categorical data and Student t-test or Mann-Whitney U test for continuous data as appropriate).
Ninety-nine COVID-19 patients and 45 non-COVID-19 patients were included.No difference was found between the rate of abnormal findings comparing COVID-19 patients and patients with other viral pneumonia (63/99 [64%] vs 27/45 [61%], p=0.94). Acute pancreatitis signs were more commonly seen in COVID-19 patients but without statistically difference between groups (14/99 [14%] vs 3/45 [6.7%], p=0.31). Bowel wall thickening was slightly more commonly seen in patients with other viral pneumonia (18/99 [18%] vs 11/45 [24%], p=0.52), however ischemic features were observed in higher rate in the COVID-19 group, although without reaching statistically significant differences (7/99 [7.1%] vs 2/45 [4.4%], p=0.75).
The rate and severity of abdominal involvement demonstrated by CT in ICU patients hospitalized for COVID-19 although high were not different to that observed in patients with other severe viral pneumoniae.
评估并比较新型冠状病毒肺炎(COVID-19)危重症患者与非严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒性肺炎危重症患者腹部CT扫描显示的受累情况及其类型。
经单中心机构审查委员会批准的回顾性研究,比较为入住重症监护病房(ICU)的COVID-19患者进行的所有腹部CT扫描结果,以及在非SARS-CoV-2病毒性肺炎ICU患者历史队列中进行的腹部CT扫描结果。评估每位患者的胆囊异常、急性胰腺炎体征、急性肾上腺梗死、肾梗死、肠壁增厚以及肠缺血的CT扫描征象。然后对COVID-19危重症患者和非COVID-19患者的结果进行比较(分类数据采用卡方检验或Fisher精确检验,连续数据根据情况采用Student t检验或Mann-Whitney U检验)。
纳入99例COVID-19患者和45例非COVID-19患者。COVID-19患者与其他病毒性肺炎患者的异常发现率无差异(63/99 [64%] 对27/45 [61%],p = 0.94)。急性胰腺炎体征在COVID-19患者中更常见,但两组之间无统计学差异(14/99 [14%] 对3/45 [6.7%],p = 0.31)。肠壁增厚在其他病毒性肺炎患者中略更常见(18/99 [18%] 对11/45 [24%],p = 0.52),然而COVID-19组中缺血特征的发生率更高,尽管未达到统计学显著差异(7/99 [7.1%] 对2/45 [4.4%],p = 0.75)。
因COVID-19住院的ICU患者腹部CT显示的受累率和严重程度虽高,但与其他严重病毒性肺炎患者观察到的情况并无差异。